Bridging Eras In Oncology: How Molecular Innovations Are Redefining Cancer Diagnosis And Therapy

Abstract

Objective: To examine how molecular diagnostic technologies are transforming cancer care and their integration with traditional methods.

Scope: This review covers developments in liquid biopsy, next-generation sequencing, circulating DNA analysis, and computational tools, analyzing clinical applications and implementation challenges.

Methods: We reviewed peer-reviewed literature from 2015 to 2024, focusing on molecular diagnostic innovations, clinical validation studies, and comparative effectiveness research.

Key Results: Molecular diagnostics demonstrate superior sensitivity for minimal residual disease detection compared to conventional methods. Liquid biopsy enables non-invasive treatment monitoring and early detection of resistance. Next-generation sequencing identifies actionable mutations in ~70% of solid tumors, directly informing treatment selection. Integration with traditional approaches improves patient outcomes and therapeutic precision.

Conclusion: While molecular innovations offer substantial advantages, optimal cancer care requires thoughtful integration of both approaches. Success depends on addressing barriers to cost, access, standardization, and training.